Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma
| Autor: | Jie Yu, Xuejuan Dong, Ping Liang, Xiaoling Yu, Xin Li, Ming-an Yu |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Cirrhosis Percutaneous complications carcinoma OncoTargets and Therapy 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Renal cell carcinoma medicine Carcinoma Pharmacology (medical) Original Research medicine.diagnostic_test business.industry Microwave ablation Magnetic resonance imaging medicine.disease renal cell Oncology microwave ablation 030220 oncology & carcinogenesis Hydrothorax Radiology business Abdominal surgery |
| Zdroj: | OncoTargets and therapy |
| ISSN: | 1178-6930 |
| DOI: | 10.2147/ott.s109783 |
| Popis: | Xuejuan Dong, Xin Li, Jie Yu, Ming-an Yu, Xiaoling Yu, Ping Liang Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, People’s Republic of China Purpose: To retrospectively review the complications of ultrasound (US)-guided percutaneous microwave ablation (MWA) of renal cell carcinoma.Patients and methods: In this study, 101 patients with 105 tumors seen from April 2006 to Feb 2014 were enrolled retrospectively. The patients were treated with US-guided percutaneous MWA and were followed up with contrast-enhanced US and computed tomography or magnetic resonance imaging at 1, 3, and 6months and every 6months thereafter.Results: Technical success was achieved in 99 of 105 tumors (94.3%). The median follow-up time was 25 (range 1.13–93.23)months. Among the 105 tumors, 26 complications in 24.8% of patients and 23 minor complications (Clavien–Dindo Grades I and II) in 21.9% of patients were noted, accounting for 88.5% of all complications. All the minor complications were cured. Three major complications (Clavien–Dindo Grade ≥III) occurred in 2.9% of the patients, accounting for 11.5% of all complications: hydrothorax in two patients and bowel injury in one. The two patients who had hydrothorax post-MWA had a history of cirrhosis and were treated with catheter drainage. The bowel injury was treated surgically. In all patients, the changes in serum creatinine and urea nitrogen levels from before to after the procedure were small.Conclusion: US-guided percutaneous MWA is a beneficial treatment for renal cell carcinoma in selected patients; however, if the renal tumor is close to the bowel, or the patient has serious comorbidities or has undergone abdominal surgery, the procedure must be performed more carefully. Keywords: microwave ablation, renal cell, complications, carcinoma |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|